Evidence map›Paper›PMID 36174779›Full record

Trial reportDiabetes research and clinical practice2022

Racial/ethnic and socioeconomic disparities in weight outcomes, cardiovascular events, and mortality in the look AHEAD trial.

Sara J Cromer, James Meigs, Deborah J Wexler

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Diabetes research and clinical practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Sara J CromerMassachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States; The Broad Institute of Harvard and MIT, Boston, MA, United States. Electronic address: scromer@mgh.harvard.edu.
James MeigsMassachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States; The Broad Institute of Harvard and MIT, Boston, MA, United States.
Deborah J WexlerMassachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.
Harvard University · USMassachusetts General Hospital · US

Funding

REAL HEALTH-Diabetes: REach Ahead for Lifestyle and Health-DiabetesR18DK102737 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI DELAHANTY, LINDA MICHELE, WEXLER, DEBORAH J · 2014 to 2018
$3.2M
The Effect of Socioeconomic Status on Outcomes in Type 2 Diabetes Clinical TrialsF32DK127545 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI CROMER, SARA JANE · 2020 to 2020
$76k
NIDDK NIH HHS F32 DK127545NIDDK NIH HHS R18 DK102737
6 · The paper itself

Abstract

backgroundIntensive lifestyle interventions (ILI) for type 2 diabetes (T2D) improve health outcomes, but participants from different races/ethnicities or socioeconomic status may not benefit equally.

methodsWithin the Look AHEAD trial, we examined achievement of the 7% weight loss goal, as well as secondary weight, cardiovascular, and mortality outcomes, by race/ethnicity and educational attainment (EA).

resultsAmong 4,640 participants (31 % Black or Hispanic, 13 % with less than a high school degree), Black and Hispanic participants were less likely than White participants to achieve 7 % weight loss in both the ILI (45.8 % v. 60.7 %, p < 0.001 and 53.0 % v. 60.7 %, p = 0.01, respectively) and diabetes support and education (DSE) arms. Contrastingly, participants with less than a high school degree were more likely in the ILI but less likely in the DSE arm to achieve this goal, with a significant arm by EA interaction. Hispanic participants and those with lowest EA also experienced decreased mortality in the ILI versus the DSE arm.

conclusionsAll Look AHEAD participant subgroups achieved greater weight loss from ILI; however, Black and Hispanic participants lost less weight than White participants in both arms, while those with lowest EA benefited disproportionately from the ILI compared to participants with higher EA.

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 2EthnicityHumansLife StyleObesitySocioeconomic FactorsWeight LossHealth disparityLifestyle interventionRace/ethnicitySocioeconomic status

Identifiers

PMID36174779
PMCPMC10966613
OpenAlexW4297399541

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.